Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

Montuschi, P.; Macagno, F.; Parente, P.; Valente, S.; Lauriola, L.; Ciappi, G.; Kharitonov, S. A.; Barnes, P. J.; Ciabatloni, G.
October 2005
Thorax;Oct2005, Vol. 60 Issue 10, p827
Academic Journal
Background: Leukotriene (LT) B4 concentrations are increased and prostaglandin (PG) E2 concentrations are decreased in exhaled breath condensate (EBC) in patients with chronic obstructive pulmonary disease (COPD). A study was undertaken to investigate the short term effects of cyclo-oxygenase (COX) inhibition on exhaled LTB4 and PGE2 concentrations in patients with COPD and to identify the COX isoform responsible for exhaled PGE2 production. Methods: Two studies were performed. A double blind, crossover, randomised, placebo controlled study with ibuprofen (400 mg qid for 2 days), a non-selective COX inhibitor, was undertaken in 14 patients with stable COPD, and an open label study with oral rofecoxib (25 mg once a day for 5 days), a selective COX-2 inhibitor, was undertaken in a different group of 16 COPD patients. EBC was collected before and after drug treatment. Exhaled LTB4 and PGE2 concentrations were measured with specific immunoassays. Results: All patients complied with treatment as indicated by a reduction in ex vivo serum thromboxane B2 concentrations (ibuprofen) and a reduction in lipopolysaccharide induced increase in ex vivo plasma PGE2 values (rofecoxib) of more than 80%. Exhaled LTB4 was increased after ibuprofen (median 175.5 (interquartile range 128.8-231.5) pg/ml v 84.0 (70.0-98.5) pg/ml, p<0.001) and exhaled PGE2 was reduced (93.5 (84.0-105-5) pg/ml v 22.0 (15.0-25.5) pg/ml, p<0.0001). Rofecoxib had no effect on exhaled LTB4 (p=0.53) or POE2 (p=0.23). Conclusions: Non-selective COX inhibition decreases PGE2 and increases LTB4 in EBC, whereas selective COX-2 inhibition has no effect on these eicosanoids. PGE2 in EBC is primarily derived from COX-1 activity, and COX inhibition may redirect arachidonic acid metabolism towards the 5-lipoxygenase pathway.


Related Articles

  • Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease. Verhoeven, Gert T.; Garrelds, Ingrid M.; Hoogsteden, Henk C.; Zijlstra, Freek J. // Mediators of Inflammation;Feb2001, Vol. 10 Issue 1, p21 

    BACKGROUND: In smoking COPD patients the bronchoalveolar lavage (BAL) fluid contains high numbers of inflammatory cells. These cells might produce arachidonic acid (AA) metabolites, which contribute to inflammation and an increased bronchomotor tone. Aims: To investigate levels of AA metabolites...

  • Inhaled cortico-steroids and COPD exacerbations.  // Infectious Disease Alert;Apr2010 Primary Care, p8 

    The article discusses research done by R. Agarwal and colleagues on inhaled corticosteroids versus placebo for preventing chronic obstructive pulmonary disease (COPD) exacerbations, published in a 2010 issue of "Chest."

  • Tiotropium better than salmeterol for treating COPD.  // GP: General Practitioner;5/12/2003, p12 

    This article reports that Chronic Obstructive Pulmonary Disease exacerbations and health resource usage are lower among patients treated with tiotropium than those given salmeterol. The tiotropium group suffered 1.07 exacerbations per patient year, compared with 1.23 and 1.49 in the salmeterol...

  • Aspirin-sensitive asthma aggrevation after toothpaste use. Hoxha, Mehmet; Piluri, Eriola; Mesonjësi, Eris; Priftanji, Alfred // Asthma Allergy Immunology / Astim Allerji Immunoloji;Dec2010, Vol. 8 Issue 3, p189 

    Hypersensitivity to aspirin is present in 5-10% of asthmatic patients and is associated with chronic rhinosinusitis and nasal polyposis, a syndrome referred to, recently as Aspirin-exacerbated respiratory disease. Menthol (oil of peppermint) is often used as flavoring in toothpastes, in candies...

  • Daclizumab: A Potential Asthma Therapy? Antoniu, Sabina A. // Recent Patents on Inflammation & Allergy Drug Discovery;Nov2010, Vol. 4 Issue 3, p214 

    Airways inflammation in asthma is triggered and maintained by CD4+ (Th2) cells which are activated by IL-2 and stimulate the eosinophilic inflammation, IgE secretion and mucus hyperproduction. Current anti-inflammatory therapies include inhaled corticosteroids, and leukotriene modifiers but they...

  • ASTHMA.  // Thorax;Dec2001 Supp, Vol. 56, piii72 

    This article presents various studies related to asthma. It is well known that anatomical dead space increases with end-inspiratory lung volume. The gradient of the relationship is regarded as an index of airway distensibility. Between 1-10% of patients on ACEI require discontinuation of therapy...

  • Arformoterol Tartrate. Cada, Dennis J.; Levien, Terri; Baker, Danial E. // Hospital Pharmacy;May2007, Vol. 42 Issue 5, p447 

    The article offers information on Arformoterol which is indicated for the long-term, maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD). It notes that the median time to steady-state peak arformoterol plasma concentration is approximately...

  • Alterações espirométricas em doenças obstrutivas: afinal, o quanto é relevante? Soares, André Luis Pinto; de Castro Pereira, Carlos Alberto; Rodrigues, Silvia Carla // Jornal Brasileiro de Pneumologia;ene/feb2013, Vol. 39 Issue 1, p56 

    Objective: To establish the upper limits for changes in FEV1, slow vital capacity (SVC), FVC, and inspiratory capacity (IC) after placebo administration in patients with airflow obstruction. Methods: One hundred and two adults with airflow obstruction (FEV1 = 62 ± 19% of predicted) were...

  • Adherence to inhaled therapy, mortality and hospital admission in COPD. J Vestbo // Thorax;Nov2009, Vol. 64 Issue 11, p939 

    BACKGROUND: Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. METHODS: Data on drug adherence from a randomised double-blind trial comparing inhaled salmeterol 50 µg + fluticasone propionate 500...


Read the Article


Sign out of this library

Other Topics